These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 39329449)
21. Flow cytometry in the differential diagnosis of lymphocyte-rich thymoma from precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma. Li S; Juco J; Mann KP; Holden JT Am J Clin Pathol; 2004 Feb; 121(2):268-74. PubMed ID: 14983942 [TBL] [Abstract][Full Text] [Related]
22. Aberrant methylation: common in thymic carcinomas, rare in thymomas. Suzuki M; Chen H; Shigematsu H; Ando S; Iida T; Nakajima T; Fujisawa T; Kimura H Oncol Rep; 2005 Dec; 14(6):1621-4. PubMed ID: 16273266 [TBL] [Abstract][Full Text] [Related]
23. [Combined thymoma (AB + B)--pathological diagnosis and clinical significance]. Chen G Zhonghua Bing Li Xue Za Zhi; 2002 Oct; 31(5):416-9. PubMed ID: 12485483 [TBL] [Abstract][Full Text] [Related]
24. High expression of KITLG is a new hallmark activating the MAPK pathway in type A and AB thymoma. Yang Z; Liu S; Wang Y; Chen Y; Zhang P; Liu Y; Zhang H; Zhang P; Tao Z; Xiong K Thorac Cancer; 2020 Jul; 11(7):1944-1954. PubMed ID: 32463597 [TBL] [Abstract][Full Text] [Related]
25. Absence of terminal deoxynucleotidyl transferase expression identifies a subset of high-risk adult T-lymphoblastic leukemia/lymphoma. Zhou Y; Fan X; Routbort M; Cameron Yin C; Singh R; Bueso-Ramos C; Thomas DA; Milton DR; Medeiros LJ; Lin P Mod Pathol; 2013 Oct; 26(10):1338-45. PubMed ID: 23702731 [TBL] [Abstract][Full Text] [Related]
26. Vascular architecture as a diagnostic marker for differentiation of World Health Organization thymoma subtypes and thymic carcinoma. Pfister F; Hussain H; Belharazem D; Busch S; Simon-Keller K; Becker D; Pfister E; Rieker R; Ströbel P; Marx A Histopathology; 2017 Apr; 70(5):693-703. PubMed ID: 27791295 [TBL] [Abstract][Full Text] [Related]
27. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients]. Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455 [TBL] [Abstract][Full Text] [Related]
28. Thymoma with loss of keratin expression (and giant cells): a potential diagnostic pitfall. Adam P; Hakroush S; Hofmann I; Reidenbach S; Marx A; Ströbel P Virchows Arch; 2014 Sep; 465(3):313-20. PubMed ID: 24923897 [TBL] [Abstract][Full Text] [Related]
29. Discovery and validation of DNA methylation markers for overall survival prognosis in patients with thymic epithelial tumors. Li S; Yuan Y; Xiao H; Dai J; Ye Y; Zhang Q; Zhang Z; Jiang Y; Luo J; Hu J; Chen C; Wang G Clin Epigenetics; 2019 Mar; 11(1):38. PubMed ID: 30832724 [TBL] [Abstract][Full Text] [Related]
30. The fine structure of thymoma, with emphasis on its differential diagnosis. A study of ten cases. Levine GD; Rosai J; Bearman RM; Polliack A Am J Pathol; 1975 Oct; 81(1):49-86. PubMed ID: 1080957 [TBL] [Abstract][Full Text] [Related]
31. Methylation and expression profiles of MGMT gene in thymic epithelial tumors. Mokhtar M; Kondo K; Namura T; Ali AH; Fujita Y; Takai C; Takizawa H; Nakagawa Y; Toba H; Kajiura K; Yoshida M; Kawakami G; Sakiyama S; Tangoku A Lung Cancer; 2014 Feb; 83(2):279-87. PubMed ID: 24388682 [TBL] [Abstract][Full Text] [Related]
32. [Expression of CD20 in thymomas and its clinical implication]. Du J; Zhou XJ; Yin HL; Lu ZF; Zhou HB Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):611-4. PubMed ID: 21092589 [TBL] [Abstract][Full Text] [Related]
33. New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China. Chen G; Marx A; Chen WH; Yong J; Puppe B; Stroebel P; Mueller-Hermelink HK Cancer; 2002 Jul; 95(2):420-9. PubMed ID: 12124843 [TBL] [Abstract][Full Text] [Related]
34. Molecular pathology of thymomas: implications for diagnosis and therapy. Marx A; Belharazem D; Lee DH; Popovic ZV; Reißfelder C; Schalke B; Schölch S; Ströbel P; Weis CA; Yamada Y Virchows Arch; 2021 Jan; 478(1):101-110. PubMed ID: 33674910 [TBL] [Abstract][Full Text] [Related]
35. Precursor B- or T-lymphoblastic lymphoma presenting with cutaneous involvement: a series of 13 cases including 7 cases of cutaneous T-lymphoblastic lymphoma. Lee WJ; Moon HR; Won CH; Chang SE; Choi JH; Moon KC; Lee MW J Am Acad Dermatol; 2014 Feb; 70(2):318-25. PubMed ID: 24314877 [TBL] [Abstract][Full Text] [Related]
37. LMO2 Is a Specific Marker of T-Lymphoblastic Leukemia/Lymphoma. Jevremovic D; Roden AC; Ketterling RP; Kurtin PJ; McPhail ED Am J Clin Pathol; 2016 Feb; 145(2):180-90. PubMed ID: 26796495 [TBL] [Abstract][Full Text] [Related]
38. Complete Blood Count Score Model Integrating Reduced Lymphocyte-Monocyte Ratio, Elevated Neutrophil-Lymphocyte Ratio, and Elevated Platelet-Lymphocyte Ratio Predicts Inferior Clinical Outcomes in Adult T-Lymphoblastic Lymphoma. Feng X; Li L; Wu J; Zhang L; Sun Z; Li X; Wang X; Yu H; Chang Y; Wu X; Zhou Z; Wang G; Li W; Li Z; Zhang X; Zhang M Oncologist; 2019 Nov; 24(11):e1123-e1131. PubMed ID: 30952822 [TBL] [Abstract][Full Text] [Related]
39. Flow cytometric analysis of lymphoid cells in thymic epithelial neoplasms. Nakajima J; Takamoto S; Oka T; Tanaka M; Takeuchi E; Murakawa T Eur J Cardiothorac Surg; 2000 Sep; 18(3):287-92. PubMed ID: 10973537 [TBL] [Abstract][Full Text] [Related]
40. A CpG Methylation Classifier to Predict Relapse in Adults with T-Cell Lymphoblastic Lymphoma. Tian XP; Su N; Wang L; Huang WJ; Liu YH; Zhang X; Huang HQ; Lin TY; Ma SY; Rao HL; Li M; Liu F; Zhang F; Zhong LY; Liang L; Lan XL; Li J; Liao B; Li ZH; Tang QL; Liang Q; Shao CK; Zhai QL; Cheng RF; Sun Q; Ru K; Gu X; Lin XN; Yi K; Shuang YR; Chen XD; Dong W; Sun C; Sang W; Liu H; Zhu ZG; Rao J; Guo QN; Zhou Y; Meng XL; Zhu Y; Hu CL; Jiang YR; Zhang Y; Gao HY; He WJ; Xia ZJ; Pan XY; Hai L; Li GW; Song LY; Kang TB; Xie D; Cai QQ Clin Cancer Res; 2020 Jul; 26(14):3760-3770. PubMed ID: 32234760 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]